Skip to main content
NIH funding notice PAR-19-360

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Closed on September 7, 2022.

Posted
August 29, 2019
Close date
September 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,761,392 in first-year total cost, median $586,201.

Most frequent study sections

  1. Science of Implementation in Health and Healthcare Study Section[SIHH]2
  2. Health Services: Quality and Effectiveness Study Section[HSQE]1

Most frequent institutions

  1. KAISER FOUNDATION RESEARCH INSTITUTE1
  2. UNIVERSITY OF COLORADO DENVER1
  3. UNIVERSITY OF ROCHESTER1
Competing awards under PAR-19-360 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Standing Orders to Improve HPV Vaccination1R01CA270276-01A1RAND, CYNTHIA MUNIVERSITY OF ROCHESTER, NY$483,215HSQE
2022PCOM2 - The Physician Communication Intervention, Version 2.01R01CA254931-01A1O'LEARY, SEAN TUNIVERSITY OF COLORADO DENVER, CO$586,201SIHH
2021Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Provider Recommendation and Advance HPV Vaccination: a Cluster Randomized Trial1R01CA255872-01A1CHAO, CHUN R.HAHN, ERIN ELIZABETHKAISER FOUNDATION RESEARCH INSTITUTE, CA$691,976SIHH

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-360: Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) | ScienceDex | ConductScience